Market Share of Europe Ovarian Cancer Diagnostics and Therapeutics Industry
The European ovarian cancer diagnostics and therapeutics market consists of several major players and is moderately fragmented. The key players in the market include AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffman-La Roche Ltd, GlaxoSmithKline PLC, Johnson and Johnson, Amneal Pharmaceuticals, Siemens Healthineers AG, among others.
Europe Ovarian Cancer Diagnostics & Therapeutics Market Leaders
F. Hoffmann-La Roche Ltd
Siemens Healthineers AG
Johnson and Johnson (Janssen Pharmaceuticals)
Eli Lilly and Company
GlaxoSmithKline PLC
*Disclaimer: Major Players sorted in no particular order